Recent studies have shown that EPHA3 is down-regulated in chemotherapy-resistant ovarian cancer cells (38) and implicated in regulation of multidrug resistance in small cell lung cancer via the PI3K signaling pathway, which has been frequently linked to taxane resistance (39, 64). This evidence concerns the gene EPHA3 and small cell lung carcinoma.